secwatch.observer — SEC 8-K summary
======================================

Issuer:     American Oncology Network, Inc. (—)
CIK:        0001839998
Form:       8-K
Filed at:   2023-04-25T23:59:59+00:00
Accession:  0001104659-23-049209
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

DTOC receives Nasdaq notice for failure to meet minimum public float requirement
--------------------------------------------------------------------------------

- Nasdaq letter on April 20, 2023 states DTOC does not meet minimum 500,000 publicly held shares (Public Float Standard).
- Company has until June 5, 2023 to submit a plan to achieve compliance; no immediate effect on listing or trading.
- DTOC intends to submit plan and references business combination agreement with American Oncology Network (announced Oct 5, 2022) to regain compliance.
- If Nasdaq rejects plan, DTOC may appeal to a Nasdaq Hearings Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1839998/000110465923049209/0001104659-23-049209-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1839998/000110465923049209/tm2313632d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-049209

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer